Anti-BCL10 antibodies are used in the immunodetection of the protein BCL10 immune signaling adaptor. In humans, the canonical protein has a reported length of 233 amino acid residues and a mass of 26.3 kDa. Its subcellular localization is in the cytoplasm. It is ubiquitously expressed across many tissue types. BCL10 is known to play an important role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation. Post-translational modifications have been described, including ubiquitination, protein cleavage and phosphorylation. Synonyms for this target antigen include CIPER, CLAP, IMD37, c-E10, mE10, B-cell lymphoma/leukemia 10, B cell CLL/lymphoma 10, and CARMEN. BCL10 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Over 60 citations in the literature describe the use of BCL10 antibodies in research. Western Blot is a widely used application for these antibodies. Flow Cytometry, Immunofluorescence, and Immunohistochemistry are also common applications.